Emyria

Subscribe to connect directly with our Management team  and be informed with our progress as we reimagine mental health care. 

Emyria is poised to drive significant growth by leveraging the cash flows from our thriving clinical services to expand our Empax Centre sites while introducing new advanced services to our suite of offerings. In parallel, We are engaging major health payers to broaden access and coverage for patients, while advancing our drug development programs in a cost-efficient manner via awarded grants. With these strategic initiatives, Emyria is set to accelerate growth, enhance patient impact, and deliver substantial returns for our investors.

About Emyria

Contact Us

Meet the Team

Announcements

New investors

Corporate Governance

Why Invest in Emyria?

Updates

Home

Pipeline

Montserrat

Emyria Limited

By gathering data with our patients we can refine patient selection, optimise care protocols, and enhance outcomes in symptom relief and quality of life. 

Our early analysis indicates strong, durable clinical outcomes, underscoring the transformative potential of our approach and setting new benchmarks in mental health care. 

Transform health outcomes and enhance quality of life for patients facing major mental health challenges. We are committed to sustainable growth by expanding our world-class clinical services and advancing a pipeline of innovative treatments. 

Through strategic partnerships with health payers and cost-efficient innovation, we aim to broaden access to our therapies, setting new standards in mental healthcare while delivering strong, long-term returns for our investors.

Australia is the only global jurisdiction with an established legal access pathway for medication-assisted therapies. This regulatory advantage allows Emyria to evaluate these emerging approaches years ahead of other markets, including the USA. 

We're on a mission to transform health outcomes for serious mental illness by leveraging Australia's unique regulatory environment to evaluate emerging therapies like MDMA-assisted therapy for PTSD and psilocybin-assisted therapy for treatment-resistant depression.   

Along the way, we gather crucial clinical data that supports our own new treatment and therapy development.

Emyria's front-line, purpose-built clinics deliver safe, effective, and compassionate care and also evaluate medication-assisted therapies. With Australia’s first Authorised Prescribers, over 20 trained therapists, and a secure supply of GMP-grade medicines, we provide evidence-based, ethically guided care to dramatically enhance patient outcomes and quality of life. We also gather valuable data from every treatment to continually improve our care models and advance new treatment options.

We recognise that the future of medication-assisted therapy will require innovation in both care models and drug treatments. That is why Emyria is investing in both domains.  Alongside our care programs we are creating strong intellectual property in drug development through global collaborations with the University of Western Australia and the National Institutes of Health (NIH) in the USA. Our key initiatives include an “MDMA 2.0,” candidate - a pro-social drug for assistive therapies, and an “anti-dyskinesia” medication for Parkinson’s disease. 

 Developing and delivering innovative, world-first mental health treatments with a focus on patient impact and real-world data.

 Over 20 trained therapists and Australia's first Authorised Prescribers and growing!

 Fit-for-purpose centers equipped with the latest technology to enhance patient outcomes.

Partnerships with the University of Western Australia and the National Institutes of Health (NIH) in the USA.

Development of "MDMA 2.0" and an "anti-dyskinesia" medication for Parkinson's disease.

 Putting patients first, applying bold science to complex care, and upholding high standards of honesty.

Championing diverse teams, and fostering respectful communication and feedback.

 Taking a disciplined, creative approach, while encouraging self-directed action.

Building strong partnerships to enhance our impact.

 Believing in a better tomorrow and creating value with every action.